Anti–IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels

✍ Scribed by Stein, Miguel L.; Villanueva, Joyce M.; Buckmeier, Bridget K.; Yamada, Yoshiyuki; Filipovich, Alexandra H.; Assa'ad, Amal H.; Rothenberg, Marc E.

• Book ID: 119280731
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 963 KB
• Volume: 121
• Category: Article
• ISSN: 1097-6825
• DOI: 10.1016/j.jaci.2008.02.033